Filing Flows › Edap TMS SA (FOCL) › Recalls, complaints & regulation
Edap TMS SA (FOCL): clinical trials
Edap TMS SA (FOCL) beyond its filings: 4 active clinical trials.
Edap TMS SA's latest quarter
Edap TMS SA, Q3 2026: revenue $9.8M (+26% year over year), operating margin -79.1%, net loss $4.5M, operating cash flow −$4.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Edap TMS SA have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.